SCHEMBL5460552

SCHEMBL5460552

CC(=O)C(C)(C)Nc1ccc(NC(C)(C)C(C)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 5/20 0.39
KMT2A Q03164 5/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 4/20 0.39
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 1/20 0.39
BRD4 O60885 1/20 0.39
NR1I2 O75469 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MB P02144 1/20 0.39
CYP1A1 P04798 1/20 0.39
CA3 P07451 1/20 0.39
CYP3A4 P08684 1/20 0.39
RARG P13631 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11350456 0.88 NAPRT (0.52) POLBSMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL29465785 0.84 GAA (0.38) POLBL3MBTL1SMN1; SMN2HTTMAPT
SCHEMBL14340359 0.77 POLB (0.37) POLBL3MBTL1SMN1; SMN2MAPTKMT2A
SCHEMBL19707372 0.75 MAPT (0.47) POLBSMN1; SMN2MAPTALDH1A1TDP1
SCHEMBL25041715 0.73 NR1H4 (0.51) SMN1; SMN2HTTMAPTKMT2AMEN1
SCHEMBL4493409 0.73 MAPT (0.47) POLBL3MBTL1SMN1; SMN2MAPTKMT2A
SCHEMBL3374091 0.73 POLB (0.58) POLBSMN1; SMN2HTTMAPTKMT2A
SCHEMBL14269954 0.73 KIF11 (0.48) POLBSMN1; SMN2HTTMAPTKMT2A
SCHEMBL1646972 0.73 NAPRT (0.46) POLBSMN1; SMN2MAPTKMT2ATSHR
SCHEMBL11245302 0.72 L3MBTL1 (0.55) POLBL3MBTL1SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence Terpetschnig, Ewald (US) 2007-12-06 US disclosed
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence Terpetschnig, Ewald (US) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence SPR, SRRT, SQLE POLB 4726/4885L3MBTL1 2272/4885SMN1; SMN2 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.